Enrique A Conterno
CIK 1476151 · Chief Executive Officer · last filed 2023-07-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$195.10M
Companies
2
Total Filings
65
Lifetime Open-Market Net
-$14.16M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KYNTRA BIO, INC. (FGEN) Delisted | Chief Executive Officer | 16,101 | $9.75 | $157.0K | -$828.9K | 22 | 2023-07-10 |
| LLY | SVP&Pres, LillyDiab & LillyUSA | 163,121 | $1196.03 | $195.10M | -$13.33M | 43 | 2019-02-20 |
Recent Filings · Page 4 of 7
65 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-12-13 | LLY | Grant (A) | — | $0 | EDGAR |
| 2017-05-08 | LLY | Sell (S) | −25,000 | -$2.07M | EDGAR |
| 2017-02-03 | LLY | Mixed | +5,434 | -$370.5K | EDGAR |
| 2017-01-31 | LLY | Grant (A) | +20,211 | $1.52M | EDGAR |
| 2016-02-03 | LLY | Mixed | +5,488 | -$385.4K | EDGAR |
| 2016-01-28 | LLY | Grant (A) | +19,953 | $1.64M | EDGAR |
| 2015-12-10 | LLY | Sell (S) | −25,000 | -$2.10M | EDGAR |
| 2015-11-16 | LLY | Mixed | +1,349 | -$61.0K | EDGAR |
| 2015-02-03 | LLY | Mixed | +7,382 | -$475.8K | EDGAR |
| 2015-01-30 | LLY | Grant (A) | +30,037 | $2.13M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.